Lymphatic vessels, shown in green, can overgrow in response to a corneal transplant. Credit: Wei-Sheng Chen, Tufts University School of Medicine
A team that included RPB-supported researchers at Tufts University School of Medicine has successfully prevented corneal inflammation, a condition that contributes to corneal tissue transplantation rejection, by inhibiting the overgrowth of lymphatic vessels.
The findings, published in Nature Communications, may have wider impact because the same overgrowth of lymphatic vessels, called Lymphangiogenesis, occurs in organ transplant rejection, cancer metastasis, lymphatic obstruction, complications of diabetes and hypertension.
April 13, 2016
RPB launches awards in data science and Diabetic Eye Disease.
Leaders of organizations that fund vision research convene in Washington DC to increase collaboration and maximize the impact of research funding for sight-threatening diseases.
An RPB grantee makes a key discovery involving genes that are essential for eye health.
RPB funds a new round of researchers and hits a milestone in supporting vision-related breakthroughs.
We welcome your generosity to help us meet our goal!
Dr. Krzysztof Palczewski develops and applies cutting-edge gene editing techniques to challenging genetic conditions.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |